Dr. Zohreh Arabpour currently holds the
position of Postdoctoral Research Associate at the University of Illinois at
Chicago. Her academic journey includes earning a Ph.D. in Tissue Engineering
from Tehran University of Medical Sciences in 2019, where she currently
dedicates her time as a full-time researcher. Her expertise encompasses a wide
array of specialized skills, including tissue engineering, cell culture, stem
cell isolation, 3D bioprinting, and regenerative medicine.
Dr. Seyed Mahbod Baharnoori is
a Research Assistant at the Department of Ophthalmology and Visual Sciences, University of Illinois in Chicago, IL, USA. His research
areas include mesenchymal stem/stromal cells, MSCs, intrastromal, mustard,
nitrogen mustard, mustard keratopathy, senescence, treatment and ocular surface.
Dr. Mohammad Soleimani is passionate about
advancing the field of cornea and Anterior Segment diseases, including Ocular
Surface Disease, through research, education, and clinical practice. He
is now a Clinical Fellowship in Ocular Regenerative Medicine at the University
of Illinois at Chicago, where he also collaborates with a multidisciplinary
team to investigate the molecular and cellular mechanisms of dry eye syndrome
and ocular surface diseases. He received an MD and completed an Ophthalmology
Residency Program and a Fellowship in Cornea at the Tehran University of
Medical Sciences, where he is now an Associate Professor. He holds the FICO and
ECFMG certifications.
Prof. Dr. Ali R. Djalilian is the Searls-Schenk
Professor of Ophthalmology at the Department of Ophthalmology and Visual
Sciences, University of Illinois at Chicago. He received his BA from Carleton
College and MD from the University of Minnesota, where he also completed his
residency and a fellowship in cornea research. He completed additional
fellowships in cornea and ocular surface disorders at Cincinnati Eye Institute;
ocular immunology and uveitis at the National Eye Institute/NIH; and epithelial
biology of the skin at NHGRI/NIH, Bethesda, Maryland. He is a recognized
authority on severe ocular surface disease, including limbal stem cell
deficiency. He bridges his clinical experience with his basic science and
translational research projects, which have been funded in part by the National
Eye Institute/NIH, Department of Defense, and Research to Prevent Blindness.
